Czechia, Aug. 10 -- Czechia based Takeda Pharmaceuticals Czech Republic s.r.o. has secured contract from Krajska nemocnice Liberec, a.s. for Immunosuppressive agents - Medicinal preparations containing the active substance Vedolizumab . The value of the contract is worth 41196735.04 CZK .
Published by HT Digital Content Services with permission from Pivotal Sources....